Latest filings (excl ownership)
DEF 14A
Definitive proxy
23 Jun 16
15-12B
Securities registration termination
5 May 16
CT ORDER
Confidential treatment order
4 May 16
10-K/A
2015 FY
Annual report (amended)
29 Apr 16
10-K
2015 FY
Annual report
4 Apr 16
8-K
Results of Operations and Financial Condition
31 Mar 16
EFFECT
Notice of effectiveness
31 Mar 16
NT 10-K
Notice of late annual filing
31 Mar 16
POS AM
Prospectus update (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
8-K
Departure of Directors or Certain Officers
4 Feb 16
8-K
BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional Indication for the BGM Galectin-3® Test
23 Dec 15
8-K
Changes in Registrant's Certifying Accountant
4 Dec 15
8-K
License and Distribution Agreement Amended
30 Nov 15
25-NSE
Exchange delisting
24 Nov 15
25-NSE/A
Exchange delisting (amended)
24 Nov 15
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Nov 15
8-K
Departure of Directors or Certain Officers
20 Nov 15
8-K
BG Medicine Reports Third Quarter 2015 Financial Results
17 Nov 15
10-Q
2015 Q3
Quarterly report
16 Nov 15
8-K
Departure of Directors or Certain Officers
25 Sep 15
8-K
BG Medicine to Begin Trading on the Otcqb
15 Sep 15
CT ORDER
Confidential treatment order
11 Sep 15
8-K
BG Medicine Announces Proposed Underwritten Public Offering
18 Aug 15
8-K
Other Events
18 Aug 15
10-Q
2015 Q2
Quarterly report
14 Aug 15
424B5
Prospectus supplement for primary offering
14 Aug 15
8-K
BG Medicine Provides Business Update and Reports Second Quarter 2015 Financial Results
14 Aug 15
424B5
Prospectus supplement for primary offering
12 Aug 15
8-K
BG Medicine Announces Payoff of Secured Term Loan
15 Jul 15
8-K
BG Medicine Announces One-for-Four Reverse Stock Split
8 Jul 15
8-K
Submission of Matters to a Vote of Security Holders
7 Jul 15
Latest ownership filings
3
Haygood Paterson Seawell Sr
27 Jun 16
4
Aram S. Adourian
4 May 16
4
PAUL R SOHMER
4 Apr 16
4
Aram S. Adourian
4 Apr 16
4
STEPHEN P HALL
4 Apr 16
4/A
STEPHEN P HALL
4 Apr 16
4/A
Aram S. Adourian
4 Apr 16
3
JEFFREY R LUBER
5 Feb 16
4
JEFFREY R LUBER
5 Feb 16
SC 13G/A
BG Medicine, Inc.
19 Jan 16
4
NOUBAR AFEYAN
11 Dec 15
3
JAMES F O OCONNOR
20 Nov 15
4
JAMES F O OCONNOR
20 Nov 15
4
NOUBAR AFEYAN
20 Nov 15
4
STELIOS PAPADOPOULOS
20 Nov 15
4
HARRY W WILCOX
20 Nov 15
SC 13G
BG Medicine, Inc.
21 Aug 15
4
PAUL R SOHMER
19 Aug 15
4
Aram S. Adourian
19 Aug 15
4
STEPHEN P HALL
19 Aug 15
SC 13D/A
BG Medicine, Inc.
3 Aug 15
4
NOUBAR AFEYAN
29 Jul 15
4
NOUBAR AFEYAN
29 Jul 15
3
Initial statement of insider ownership
16 Jul 15
4
EDWIN M KANIA JR
16 Jul 15
SC 13D/A
BG Medicine, Inc.
26 May 15
3
HARRY W WILCOX
22 May 15
SC 13G/A
BG Medicine, Inc.
17 Feb 15
SC 13G/A
BG Medicine, Inc.
13 Feb 15
SC 13D/A
BG Medicine, Inc.
19 Dec 14
SC 13G
BG Medicine, Inc.
10 Nov 14
SC 13G
BG Medicine, Inc.
11 Apr 14
SC 13G/A
BG Medicine, Inc.
14 Feb 14
SC 13G/A
BG Medicine, Inc.
21 Oct 13
SC 13D/A
NEWCOGEN GROUP LLC
26 Feb 13
SC 13D
NEWCOGEN GROUP LLC
22 Feb 11